about
Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.Proniosomes derived niosomes: recent advancements in drug delivery and targeting.Development and characterisation of levosulpiride-loaded suppositories with improved bioavailability in vivo.Novel piroxicam-loaded nanospheres generated by the electrospraying technique: physicochemical characterisation and oral bioavailability evaluation.Irinotecan-loaded double-reversible thermogel with improved antitumor efficacy without initial burst effect and toxicity for intramuscular administration.Effect of hydroxypropylcellulose and Tween 80 on physicochemical properties and bioavailability of ezetimibe-loaded solid dispersion.Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration.Novel revaprazan-loaded gelatin microsphere with enhanced drug solubility and oral bioavailabilityFlurbiprofen-loaded nanoparticles prepared with polyvinylpyrrolidone using Shirasu porous glass membranes and a spray-drying technique: nano-sized formation and improved bioavailabilityAmniotic membrane extract-loaded double-layered wound dressing: evaluation of gel properties and wound healingNovel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effectInfluence of levodropropizine and hydroxypropyl-β-cyclodextrin association on the physicochemical characteristics of levodropropizine loaded in hydroxypropyl-β-cyclodextrin microcontainers: Formulation and in vitro characterizationRevaprazan-loaded surface-modified solid dispersion: physicochemical characterization and in vivo evaluationRifampicin-loaded nanotransferosomal gel for treatment of cutaneous leishmaniasis: passive targeting via topical routeDevelopment of levosulpiride-loaded solid lipid nanoparticles and their in vitro and in vivo comparison with commercial product
P50
Q42373834-C674D6CF-96E3-4B96-81C3-F684D22E0027Q47355869-54F22D9B-59BA-49B7-8581-D3FD7DB15A12Q48046116-214CB136-A680-444F-83E6-1898F5873E2DQ51328469-B03BA4B3-D4E2-4C4D-AFDF-C19F3D28522EQ52892527-3552E312-B4DD-4E54-A857-26F87D48DBD0Q53212467-8697EB14-6B2B-4486-8119-A5695155C727Q53764564-BB45A163-BC4C-48EA-8A60-2F1C8CABCB5CQ57290358-26136F2E-5AEC-4193-8A65-E6696AB55AA8Q86210063-AC77C6D3-9F23-4245-B7E6-C41CF01E1259Q86666134-4D9922A2-581B-4C04-976F-A28D2B777405Q87317906-E2EE94B3-BD6D-4EA5-9DF1-DB87BEC1FF0AQ91462614-C1100731-3813-4377-9C17-D3B0CC0B6CA5Q92452651-A364DF9A-5257-412E-BAFE-C93C38506283Q92510308-4CC247E6-E2F5-4196-AE50-5959C939EBDBQ92512820-3C9256ED-9BBE-42CF-9505-92BED98177AA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fakhar Ud Din
@ast
Fakhar Ud Din
@en
Fakhar Ud Din
@es
Fakhar Ud Din
@nl
type
label
Fakhar Ud Din
@ast
Fakhar Ud Din
@en
Fakhar Ud Din
@es
Fakhar Ud Din
@nl
prefLabel
Fakhar Ud Din
@ast
Fakhar Ud Din
@en
Fakhar Ud Din
@es
Fakhar Ud Din
@nl
P106
P31
P496
0000-0001-9537-4897